Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.01.2019 | Case report

Insulin-glargine

Hypoglycaemia and hypersensitivity reaction: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
Patients demographics details (age and sex) have been obtained via direct communication with the author.
 
2
Patients demographics details (age and sex) have been obtained via direct communication with the author.
 
Literatur
Zurück zum Zitat Ku EJ, et al. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice. Diabetes, Obesity and Metabolism 21: 173-177, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1111/dom.13476 - South Korea Ku EJ, et al. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice. Diabetes, Obesity and Metabolism 21: 173-177, No. 1, Jan 2019. Available from: URL: http://​doi.​org/​10.​1111/​dom.​13476 - South Korea
Metadaten
Titel
Insulin-glargine
Hypoglycaemia and hypersensitivity reaction: 2 case reports
Publikationsdatum
01.01.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-57261-2

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Lisinopril

Case report

Adalimumab

Case report

Warfarin